BioLife Solutions, Inc. (BLFS) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST
Company Participants
Troy Wichterman – Chief Financial Officer
Roderick de Greef – CEO & Chairman
Conference Call Participants
Paul Knight – KeyBanc Capital Markets Inc., Research Division
Matthew Stanton – Jefferies LLC, Research Division
Steven Etoch – Stephens Inc., Research Division
Brendan Smith – TD Cowen, Research Division
Thomas Flaten – Lake Street Capital Markets, LLC, Research Division
Presentation
Operator
Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions Third Quarter 2025 Shareholder and Analyst Conference Call. [Operator Instructions] I will now turn the call over to Troy Wichterman, Chief Financial Officer of BioLife Solutions. Please go ahead.
Troy Wichterman
Chief Financial Officer
Thank you, operator. Good afternoon, everyone, and thank you for joining the BioLife Solutions 2025 Third Quarter Earnings Conference Call. On the call with me today is Roderick de Greef, CEO and Chairman of the Board. We will cover business highlights and financial performance for the quarter and provide an update for our increased 2025 revenue guidance as adjusted for the sale of our evo Cold Chain product line. Earlier today, we issued a press release announcing our financial results and operational highlights for the third quarter of 2025, which is available at biolifesolutions.com.
As a reminder, during this call, we will make forward-looking statements. These statements are subject to risks and uncertainties that can be found in our SEC filings. These statements speak only as of the date given, and we undertake no obligation to update them. We will also speak to non-GAAP or adjusted results. Reconciliations of GAAP to non-GAAP or adjusted financial metrics are included in the press release we issued this afternoon.
Now I’d like to turn the call over to Rod de Greef, Chairman and
